CL2004000751A1 - PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREV - Google Patents
PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREVInfo
- Publication number
- CL2004000751A1 CL2004000751A1 CL2004000751A CL2004000751A CL2004000751A1 CL 2004000751 A1 CL2004000751 A1 CL 2004000751A1 CL 2004000751 A CL2004000751 A CL 2004000751A CL 2004000751 A CL2004000751 A CL 2004000751A CL 2004000751 A1 CL2004000751 A1 CL 2004000751A1
- Authority
- CL
- Chile
- Prior art keywords
- combination
- pharmaceutical
- treatment
- sodium bicarbonate
- eletripan
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMBINACION ELETRIPTAN, O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES, Y BICARBONATO DE SODIO. LA COMBINACION PROPORCIONA UNA ABSORCION RAPIDA DE ELETRIPTAN CUANDO SE TOMA POR VIA ORAL. LA COMBINACION ES UTIL PARA EL TRATAMIENTO O LA PREVENCION DE UNA ENFERMEDAD PARA LA QUE ES INDICADO UN AGENTE AGONISTA DED 5-HT1, PARTICULARMENTE EN EL TRATAMIENTO DE UNA MIGRANA O PARA LA PREVENCION DE UNA RECURRENCIA DE MIGRANA.ELETRIPTAN COMBINATION, OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS, AND SODIUM BICARBONATE. THE COMBINATION PROVIDES A FAST ABSORPTION OF ELETRIPTAN WHEN IT IS TAKEN BY ORAL. THE COMBINATION IS USEFUL FOR THE TREATMENT OR PREVENTION OF AN ILLNESS FOR WHICH A DED 5-HT1 AGONIST AGENT IS INDICATED, PARTICULARLY IN THE TREATMENT OF A MIGRANE OR FOR THE PREVENTION OF A MIGRANE RECURRENCE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0308469A GB0308469D0 (en) | 2003-04-11 | 2003-04-11 | Pharmaceutical combination |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2004000751A1 true CL2004000751A1 (en) | 2005-02-25 |
Family
ID=9956666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2004000751A CL2004000751A1 (en) | 2003-04-11 | 2004-04-07 | PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREV |
Country Status (3)
Country | Link |
---|---|
CL (1) | CL2004000751A1 (en) |
GB (1) | GB0308469D0 (en) |
GT (1) | GT200400060A (en) |
-
2003
- 2003-04-11 GB GB0308469A patent/GB0308469D0/en not_active Ceased
-
2004
- 2004-04-01 GT GT200400060A patent/GT200400060A/en unknown
- 2004-04-07 CL CL2004000751A patent/CL2004000751A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
GT200400060A (en) | 2004-12-23 |
GB0308469D0 (en) | 2003-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2004000643A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A 5-HT 1B / 1D AGONIST AND A SELECTIVE CYCLLOXYGENASA-2 INHIBITOR, USEFUL IN THE TREATMENT OF MIGRANE. | |
BRPI0408396A (en) | orally consumable, rapidly dissolving films containing pharmaceutically active agents | |
CY1111458T1 (en) | DOSAGE FORMS OF GENERAL LINEAR, ANAVARASUS, ORAL FENTANYL AND METHODS OF ADMINISTRATION | |
AR062860A1 (en) | THERAPEUTIC COMBINATIONS 482 | |
NO20062504L (en) | Compositions and dosage forms for improved absorption | |
ATE493973T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN | |
EA200901393A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE | |
DK1185253T3 (en) | Oral preparation for administration of a solid combination of tramadol and diclofenac | |
MXPA05007609A (en) | CaSR ANTAGONIST. | |
RS50768B (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
ES2190205T3 (en) | COMBINATION FOR THE TREATMENT OF THE ALCOHOL DEPENDENCE CONTAINING AN OPIOID ANTAGONIST AND A NMDA RECEPTOR COMPLEX MODULATOR. | |
ATE287264T1 (en) | ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE | |
ATE499939T1 (en) | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN POLYMORPHO A | |
DE602004005564D1 (en) | Pharmaceutical composition for thrombin peptide derivatives | |
WO2005007137A3 (en) | Tablets containing ambroxol | |
CO5580741A2 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A 5HT1 RECEIVER AGONIST | |
AR026254A1 (en) | THE USE OF A CONTROLLED RELEASE PREPARATION FOR THE PREPARATION OF A MEDICINAL PRODUCT TO INCREASE THE DOSE OR SYSTEM EXPOSURE OF A PHARMACO THAT INHIBITS PHOSPHODESTERASE 4 | |
AR038858A1 (en) | COMBINATION | |
UY26171A1 (en) | PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF LATE APPEARANCE DYSKINESIA | |
CL2004000751A1 (en) | PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREV | |
EA200702386A1 (en) | SOLID PHARMACEUTICAL COMPOSITION FOR LONG-TERM EXEMPTION OF 1- (2,3,4-TRIMETOXIBENZYL) PIPERAZINE AND METHOD FOR ITS PREPARATION | |
AR044009A1 (en) | PHARMACEUTICAL COMBINATION INCLUDING ELETRIPTAN AND SODIUM BICARBONATE | |
AR033807A1 (en) | USE OF (R) - (-) - 2- [5- (4-FLUOROPHENYL) -3-PIRIDYLMETHYLAMINOME] -CROMANO AND ITS ACCEPTABLE SALTS FOR PHYSIOLOGICAL USE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
EA200601015A1 (en) | ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION | |
EP1064967A3 (en) | 5HT1 receptor agonists, caffeine and either a COX-2 inhibitor or NSAID for the treatment of migraine |